Synthesis of 1, 2, 3-triazole linked 4 (3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus S Gatadi, J Gour, M Shukla, G Kaul, S Das, A Dasgupta, S Malasala, ... European Journal of Medicinal Chemistry 157, 1056-1067, 2018 | 57 | 2018 |
Rationally designed curcumin based ruthenium (ii) antimicrobials effective against drug-resistant Staphylococcus aureus P Srivastava, M Shukla, G Kaul, S Chopra, AK Patra Dalton Transactions 48 (31), 11822-11828, 2019 | 42 | 2019 |
Repurposing disulfiram for treatment of Staphylococcus aureus infections R Thakare, M Shukla, G Kaul, A Dasgupta, S Chopra International journal of antimicrobial agents 53 (6), 709-715, 2019 | 41 | 2019 |
Synthesis and biological evaluation of 2, 4, 5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis UB Karale, VS Krishna, EV Krishna, AS Choudhari, M Shukla, ... European Journal of Medicinal Chemistry 178, 315-328, 2019 | 38 | 2019 |
Update on drug-repurposing: is it useful for tackling antimicrobial resistance? G Kaul, M Shukla, A Dasgupta, S Chopra Future Microbiology 14 (10), 829-831, 2019 | 38 | 2019 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis S Malasala, MN Ahmad, R Akunuri, M Shukla, G Kaul, A Dasgupta, ... European Journal of Medicinal Chemistry 212, 112996, 2021 | 37 | 2021 |
Novel 1, 3, 4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis VB Makane, VS Krishna, EV Krishna, M Shukla, B Mahizhaveni, S Misra, ... Future Medicinal Chemistry 11 (6), 499-510, 2019 | 33 | 2019 |
Vancomycin Derivative Inactivates Carbapenem-Resistant Acinetobacter baumannii and Induces Autophagy P Sarkar, S Samaddar, V Ammanathan, V Yarlagadda, C Ghosh, ... ACS Chemical Biology 15 (4), 884-889, 2020 | 29 | 2020 |
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis VB Makane, VS Krishna, EV Krishna, M Shukla, B Mahizhaveni, S Misra, ... European Journal of Medicinal Chemistry 164, 665-677, 2019 | 25 | 2019 |
Targeted antibacterial activity guided by bacteria-specific nitroreductase catalytic activation to produce ciprofloxacin KA Pardeshi, TA Kumar, G Ravikumar, M Shukla, G Kaul, S Chopra, ... Bioconjugate Chemistry 30 (3), 751-759, 2019 | 24 | 2019 |
Synthesis and evaluation of new quinazolin-4 (3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis S Gatadi, J Gour, M Shukla, G Kaul, A Dasgupta, YV Madhavi, S Chopra, ... European Journal of Medicinal Chemistry 175, 287-308, 2019 | 23 | 2019 |
Synthesis and evaluation of new 4-oxoquinazolin-3 (4H)-yl) benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant … S Gatadi, J Gour, M Shukla, G Kaul, A Dasgupta, YV Madhavi, S Chopra, ... Bioorganic Chemistry 83, 569-579, 2019 | 22 | 2019 |
Repurposing nonantibiotic drugs as antibacterials R Thakare, G Kaul, M Shukla, P Kesharwani, N Srinivas, A Dasgupta, ... Drug Discovery Targeting Drug-Resistant Bacteria, 105-138, 2020 | 19 | 2020 |
Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium … SK Sahoo, B Rani, NB Gaikwad, MN Ahmad, G Kaul, M Shukla, S Nanduri, ... European Journal of Medicinal Chemistry 222, 113580, 2021 | 16 | 2021 |
Structure based design, synthesis and evaluation of new thienopyrimidine derivatives as anti-bacterial agents S Malasala, A Polomoni, MN Ahmad, M Shukla, G Kaul, A Dasgupta, ... Journal of Molecular Structure 1234, 130168, 2021 | 14 | 2021 |
Synthesis of new 3-phenylquinazolin-4 (3H)-one derivatives as potent antibacterial agents effective against methicillin-and vancomycin-resistant Staphylococcus aureus (MRSA and … S Gatadi, J Gour, G Kaul, M Shukla, A Dasgupta, R Akunuri, R Tripathi, ... Bioorganic chemistry 81, 175-183, 2018 | 14 | 2018 |
Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents S Malasala, MN Ahmad, J Gour, M Shukla, G Kaul, A Akhir, S Gatadi, ... Journal of Molecular Structure 1218, 128493, 2020 | 13 | 2020 |
Metal-and phenol-free synthesis of biaryl ethers: access to dibenzobistriazolo-1, 4, 7-oxadiazonines and vancomycin-like glyco-macrocycles as antibacterial agents K Singh, G Sharma, M Shukla, R Kant, S Chopra, SK Shukla, RP Tripathi The Journal of Organic Chemistry 83 (24), 14882-14893, 2018 | 12 | 2018 |
Peptide Nanostructure-Mediated Antibiotic Delivery by Exploiting H2S-Rich Environment in Clinically Relevant Bacterial Cultures N Singh, R Singh, M Shukla, G Kaul, S Chopra, KB Joshi, S Verma ACS Infectious Diseases 6 (9), 2441-2450, 2020 | 11 | 2020 |
Cudraflavone C from Artocarpus hirsutus as a Promising Inhibitor of Pathogenic, Multidrug-Resistant S. aureus, Persisters, and Biofilms: A New Insight into a … MT Meenu, G Kaul, M Shukla, KV Radhakrishnan, S Chopra Journal of Natural Products 84 (10), 2700-2708, 2021 | 10 | 2021 |